49 evolution-"https:"-"https:"-"MUNSTER-TECHNOLOGICAL-UNIVERSITY" Postdoctoral positions at Argonne
Sort by
Refine Your Search
-
Argonne National Laboratory’s Accelerator Science Division is seeking a Postdoctoral Appointee to contribute to the development of a Sub- THz Collinear Structural Wakefield Accelerator
-
The Applied Materials Division, Process R&D and Scale up Group at Argonne National Laboratory is seeking a Postdoctoral candidate to conduct general research in material science and electrochemistry related to next generation cathode material synthesis for lithium-ion and sodium batteries. The...
-
of these systems are insufficient to cover the diversity of human-driven experimental activities. The development of multi-appendage, dexterous robots with embodied intelligence is a key to closing this gap
-
enable physics-informed AI agents that accelerate discovery in catalysis science. The successful candidate will focus on the development and application of machine learning and AI approaches to analyze
-
in experimental physics and superconducting device development, with a focus on advancing multipixel single-photon camera technology and multiplexed readout for quantum information science applications
-
The Chemical and Fuel Cycle Technologies division is seeking a Postdoctoral Appointee to join an R&D team conducting use-inspired research supporting the development of molten salt technologies
-
of experimental quantum communication hardware development, optical memory qubit characterization, and fiber-based networking demonstrations using novel memory qubits. The goal is to employ the natural telecom
-
and integrate emerging AI techniques (e.g., agentic workflows, LLMs) into scientific problems, ensuring methods effectively solve real domain challenges. Advanced Model Development: Design and debug
-
and characterizing new materials and membranes for critical minerals separations. The ideal candidate will have expertise in membrane development and electrochemical processes. This position will be
-
aims to revolutionize the development of therapeutic platforms for IDPs, creating significant advancements in cancer research and treatment strategies. As part of a collaborative initiative with the